#United States #Arlington #GE HealthCare #Mammography #Hologic

Exploring the Future of Breast Imaging in the U.S.

The IMV Medical Information Division, under Science and Medicine Group, has released a vital report outlining critical trends in the U.S. breast imaging landscape for 2025. This document is based on a comprehensive survey conducted with over 200 mammography professionals in hospitals and imaging facilities across the nation, giving a clear view of what lies ahead in this essential healthcare sector.

Key Findings and Trends

Anticipated Growth in Procedures

One striking prediction from the report is that approximately 78% of professionals expect a rise in mammography procedures in 2025 compared to the previous year. This anticipated increase correlates with the projected rise in new cases of invasive breast cancer and ductal carcinoma in situ. Such projections highlight the pressing need for expanded imaging services and better equipment.

Breakdown of Procedure Types

The study indicates that mammography procedures are set to grow at a high single-digit percentage year-over-year. More than 60% of these procedures will be diagnostic in nature, while over a third will be classified as screening. This data underscores the importance of having efficient processes in place to handle the varying needs of patients.

Equipment Preferences and Patient Focus

In terms of equipment, Hologic continues to be the most frequently considered original equipment manufacturer (OEM), followed closely by GE and Siemens. Interestingly, patient satisfaction has emerged as the foremost priority for many departments, implying a shift towards more patient-centered care in imaging practices.

A Resource for Decision-Makers

The IMV report stands as a strategic tool for decision-makers in the medical imaging field. With more than 160 detailed charts and exhibits spread across 155 pages, it provides:

• - A benchmark for procedure volumes and installation metrics based on hospital size and type.
• - Insights into the equipment market, aiding organizations in anticipating future purchasing behavior among OEMs.
• - The latest advancements in biopsy techniques and various breast imaging modalities, fostering an understanding of emerging trends.
• - Guidance for developing data-backed strategies for marketing, investments, service offerings, and product development.

Who Will Benefit from This Report?

The findings of this report are crucial for a diverse audience among medical imaging professionals, including:

• - Product and marketing managers at certain OEMs like Hologic, GE Healthcare, and Siemens.
• - Sales and commercial personnel looking to leverage growth markets in the imaging sector.
• - Radiology department heads and hospital administration teams.
• - Strategic consultants and advisors within imaging.
• - Private equity and investment analysts interested in the diagnostic imaging market.
• - Service providers focusing on OEM versus third-party service trends.

Conclusion

The 2025 Mammography and Breast Imaging Market Outlook Report not only forecasts promising changes for the breast imaging field but also establishes a research foundation for improving services. It is now available for purchase, ensuring that those within the imaging profession stay informed and equipped to navigate an evolving landscape. For custom research or consultations, professionals can reach out to the IMV sales team. With patient care at the forefront, these insights are ripe for integrating advanced systems into health practices, thereby enhancing the experience for both patients and healthcare providers alike.